Heron Therapeutics's total assets for Q4 2024 were $233.15M, an increase of 5.60% from the previous quarter. HRTX total liabilities were $266.80M for the fiscal quarter, a 2.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.